interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Nepafenac

Generic competition · all medicines · read 12 November 2026

Is there a generic of Nepafenac, and who makes it?

Nepafenac appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Nepafenac1 dosage-form group in the Orange Book
0generic makers listed
  1. Nepafenac appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Suspension/Drops, Ophthalmic

Brand listed, no generic listed as marketed

Brand listed as marketed: Ilevro and Nevanac. No generic is listed as marketed.

200520102015202020252030203501brand 2005data datePatent 7834059 listed to expire 31 January 2027Patent 9662398 listed to expire 1 December 2030Patent 8921337 listed to expire 31 March 2032
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 31 January 2027Patent 7834059
  • 1 December 2030Patent 9662398 drug product
  • 31 March 2032Patent 8921337 drug product

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.